Publications

ANTONIO CANO SANCHEZ publications

383 results

2026

  1. Associations Between Reproductive Disorders and Specific Physical, Mental, Personality, and Social Characteristics: A Narrative Review

    Health Science Reports, Vol. 9, Núm. 3

  2. Pregnancy and perinatal complications in untreated subfertile couples following singleton spontaneous conception: a narrative review

    Reproductive Biology and Endocrinology, Vol. 24, Núm. 1

2025

  1. Effects of L-Arginine on Bone Metabolism: Evidence from In Vitro and In Vivo Models

    International Journal of Molecular Sciences, Vol. 26, Núm. 17

  2. Genetic variants of the androgen receptor and frailty in postmenopausal women

    Gynecological Endocrinology, Vol. 41, Núm. 1

  3. Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies

    Advances in Therapy, Vol. 42, Núm. 2, pp. 1147-1164

  4. The Final Phases of Ovarian Aging: A Tale of Diverging Functional Trajectories

    Journal of Clinical Medicine, Vol. 14, Núm. 16

2024

  1. Association between anxiety and frailty in postmenopausal women

    Gynecological Endocrinology, Vol. 40, Núm. 1

  2. Effect of fezolinetant on sleep disturbance and impairment during treatment of vasomotor symptoms due to menopause

    Maturitas, Vol. 186

  3. Fezolinetant impact on health-related quality of life for vasomotor symptoms due to the menopause: Pooled data from SKYLIGHT 1 and SKYLIGHT 2 randomised controlled trials

    BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 131, Núm. 9, pp. 1296-1305

2023

  1. Analysis of the impact, patterns of care, and perspectives of patients and physicians about moderate-to-severe menopausal vasomotor symptoms in Spain

    Clinica e Investigacion en Ginecologia y Obstetricia, Vol. 50, Núm. 4

  2. Both reduced ovarian reserve and severe semen alterations are overrepresented in couples seeking assisted reproductive technology treatment for the first time: a cross-sectional study

    Reproductive Health, Vol. 20, Núm. 1

  3. Breaking down barriers for prescribing and using hormone therapy for the treatment of menopausal symptoms: an experts’ perspective

    Expert Review of Clinical Pharmacology, Vol. 16, Núm. 6, pp. 507-517

  4. Corrigendum to “Evaluation of the impact, treatment patterns, and patient and physician perceptions of vasomotor symptoms associated with menopause in Europe and the United States” [Maturitas 164 (October 2022) 38–45] (Maturitas (2022) 164 (38–45), (S0378512222001360), (10.1016/j.maturitas.2022.06.008))

    Maturitas

  5. Erratum to: Building bridges for innovation in ageing: Synergies between action groups of the EIP on AHA (The journal of nutrition, health & aging, (2017), 21, 1, (92-104), 10.1007/s12603-016-0803-1)

    Journal of Nutrition, Health and Aging

  6. Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study

    The Lancet, Vol. 401, Núm. 10382, pp. 1091-1102

  7. Genetic variants of the vitamin D receptor are related to dynapenia in postmenopausal women

    Maturitas, Vol. 171, pp. 40-44

  8. Long-term effect of chemotherapy after ovarian decortication on the ovarian function in women surviving cancer

    Journal of Assisted Reproduction and Genetics, Vol. 40, Núm. 12, pp. 2827-2834

  9. Mediterranean diet for cancer prevention and survivorship

    Maturitas, Vol. 178

  10. Prophylactic mastectomy and bilateral salpingo-oophorectomy in patients with breast cancer: a systematic review of postsurgical sexual function and menopausal hormone therapy symptom mitigation

    Sexual medicine reviews, Vol. 12, Núm. 1, pp. 3-13

  11. Rodent Animal Models of Endometriosis-Associated Pain: Unmet Needs and Resources Available for Improving Translational Research in Endometriosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 3